FDA Approves Amgen’s Infliximab Biosimilar Treatment
Rituximab-abbs Available in the U.S.; Plus Upadacitinib in Phase 3 Trials for PsA
FDA Action on Loperamide Misuse; Plus Phase 1 Trials for BAT2506 Biosimilar Begin
Clinical Insights into Gout Management: Rheumatology Drugs at a Glance Pt. 4
FDA Approves the Biosimilar Hadlima (Adalimumab-bwwd)
Amgen Wins U.S. Patent Battle on Arthritis Drug Enbrel
Samsung Bioepis Humira Biosimilar Wins FDA Approval
Subcutaneous CT-P13 Injection Evaluated for Safety & Efficacy of in RA Patients
Ixekizumab vs. Adalimumab for PsA: How Do They Compare?
- 1
- 2
- 3
- …
- 31
- Next Page »